Clinical trial
Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan on Proteinuria in Diabetic Nephropathy Patients
NCT06491940 is registered in ClinicalTrials.gov with RESnTEC, Institute of Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan on Proteinuria in Diabetic Nephropathy Patients
- Lead sponsor
- RESnTEC, Institute of Research
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2024
- Completion date
- July 31, 2025
- Enrollment
- 234 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.